PHS
IOBT

PFM Health Sciences’s IO Biotech IOBT Stock Holding History

PFM Health Sciences’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,972,073
Closed -$2.74M – 80
2025
Q2 		$2.74M Sell
1,972,073
-369,034
-16% -$423K 0.23% 47
2025
Q1 		$2.55M Hold
2,341,107
– – 0.19% 50
2024
Q4 		$2.15M Hold
2,341,107
– – 0.13% 71
2024
Q3 		$2.46M Hold
2,341,107
– – 0.14% 63
2024
Q2 		$2.74M Hold
2,341,107
– – 0.14% 64
2024
Q1 		$4.05M Hold
2,341,107
– – 0.19% 73
2023
Q4 		$4.4M Buy
2,341,107
+987,654
+73% +$1.18M 0.26% 54
2023
Q3 		$1.91M Buy
1,353,453
+740,740
+121% +$1.3M 0.09% 69
2023
Q2 		$1.2M Buy
612,713
+105,073
+21% +$205K 0.05% 80
2023
Q1 		$952K Hold
507,640
– – 0.04% 75
2022
Q4 		$1.17M Sell
507,640
-1,651,515
-76% -$4.37M 0.04% 81
2022
Q3 		$5.85M Hold
2,159,155
– – 0.21% 72
2022
Q2 		$10.1M Buy
2,159,155
+797,011
+59% +$4.88M 0.38% 60
2022
Q1 		$6.65M Hold
1,362,144
– – 0.25% 60
2021
Q4 		$7.74M Buy
+1,362,144
New +$13.2M 0.26% 58

Other funds holding IOBT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

PFM Health Sciences's IOBT Position: Q3 2025 in Review

PFM Health Sciences sold out of IO Biotech (IOBT) in Q3 2025, closing a stake of 1,972,073 shares — an estimated $2.74M sold.

PFM Health Sciences first reported a position in IOBT in Q4 2021 and held it in 15 quarters. The position peaked at $10.1M in Q2 2022. 21 funds tracked by Wall St. Rank hold IOBT as of Q3 2025.

  • PFM Health Sciences reported no remaining IO Biotech position as of Q3 2025 after selling out during the quarter.
  • PFM Health Sciences sold 1,972,073 IO Biotech shares in Q3 2025, an estimated $2.74M.
  • PFM Health Sciences first reported a position in IO Biotech in Q4 2021 and held it in 15 quarters.
  • PFM Health Sciences's IO Biotech position peaked at $10.1M in Q2 2022.
  • 21 funds tracked by Wall St. Rank held IO Biotech as of Q3 2025.

Based on PFM Health Sciences's 13F filing for Q3 2025, filed 14 Nov 2025.